Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesXIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023The Company provides 2025 revenue